Literature DB >> 19465862

Preclinical evaluation of a novel fiber compound MR guidewire in vivo.

Nils A Krämer1, Sascha Krüger, Sebastian Schmitz, Marita Linssen, Heinz Schade, Steffen Weiss, Elmar Spüntrup, Rolf W Günther, Arno Bücker, Gabriele A Krombach.   

Abstract

PURPOSE: Interventional magnetic resonance imaging requires dedicated and MR-compatible devices. The guidewire is a key item for intravascular interventions. Mechanical stability, good visibility during real-time imaging, and RF safety are essential. A novel fiber-compound MR guidewire (GW) was evaluated in different MR-guided interventional scenarios.
MATERIALS AND METHODS: The GW (diameter 0.032") consists of a fiber-compound produced using a micropultrusion technique doped with iron particles and a 10-cm Nitinol tip. Several iron splints are additionally attached at regular distances to visualize GW-movement. A protective polymer jacket with hydrophilic coating covers the core material. As approved by the government committee on animal investigations, the GW was evaluated in 5 pigs. Under complete MR-guidance, catheterization of the carotid and renal arteries, segmental arteries of the kidneys, the contralateral inguinal artery, and the left ventricle was performed using real-time gradient echo sequences in a 1.5 Tesla scanner. Different interventional applications including balloon dilatation, stent deployment, and embolization of small vessels were investigated. The time to probe the vessels under magnetic resonance imaging guidance and visibility of the GW are assessed. Handling and visibility under fluoroscopy were compared with a standard Nitinol guidewire as a benchmark.
RESULTS: On real-time magnetic resonance imaging, the iron-induced artifacts enabled a distinct visualization of the GW shaft and of its markings with a mean size of 2.6 mm and 5.4 mm, respectively. This facilitated fast navigation to the target vessels (averages: renal arteries 16 seconds, carotid artery 5 seconds, and contralateral inguinal artery 42 seconds.) with an exact depiction of the respective vessel. All interventional procedures were performed successfully. No GW-related side effects as kinking or breakage of the wire or GW induced blood-clotting were observed. All interventionalists assessed handling of the GW to be nearly equal in terms of stiffness, flexibility, and guidance compared with a standard Nitinol guidewire. X-ray visibility was less distinct but still diagnostically good.
CONCLUSION: With the aid of the GW, different fully real-time MR-guided endovascular interventions become feasible.

Entities:  

Mesh:

Year:  2009        PMID: 19465862     DOI: 10.1097/RLI.0b013e3181a66ab5

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Nanocomposite Carriers for Transarterial Chemoembolization of Liver Cancer.

Authors:  Dong-Hyun Kim; Andrew C Larson
Journal:  Interv Oncol 360       Date:  2016-11-17

2.  Radial MRI with variable echo times: reducing the orientation dependency of susceptibility artifacts of an MR-safe guidewire.

Authors:  Katharina E Schleicher; Michael Bock; Klaus Düring; Stefan Kroboth; Axel J Krafft
Journal:  MAGMA       Date:  2017-08-02       Impact factor: 2.310

3.  Differences in clotting parameters between species for preclinical large animal studies of cardiovascular devices.

Authors:  Toshihide Mizuno; Tomonori Tsukiya; Yoshiaki Takewa; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2017-11-09       Impact factor: 1.731

4.  Segmented nitinol guidewires with stiffness-matched connectors for cardiovascular magnetic resonance catheterization: preserved mechanical performance and freedom from heating.

Authors:  Burcu Basar; Toby Rogers; Kanishka Ratnayaka; Adrienne E Campbell-Washburn; Jonathan R Mazal; William H Schenke; Merdim Sonmez; Anthony Z Faranesh; Robert J Lederman; Ozgur Kocaturk
Journal:  J Cardiovasc Magn Reson       Date:  2015-11-30       Impact factor: 5.364

5.  Multimodal Imaging of Nanocomposite Microspheres for Transcatheter Intra-Arterial Drug Delivery to Liver Tumors.

Authors:  Dong-Hyun Kim; Weiguo Li; Jeane Chen; Zhuoli Zhang; Richard M Green; Sui Huang; Andrew C Larson
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.